Table 1.

Competition-inhibition assay for CMAB008 and infliximab

Times	EC50 (μg/mL)		Relative affinity activity (%)
	Infliximab	CMAB008
1	0.149	0.144	103.5
2	0.127	0.140	90.7
3	0.142	0.153	92.8
Mean±SD	0.139±0.011	0.146±0.007	95.7±6.84